PROFOUNDA, INC.

Profound Insights Lead to Better Products.

RHINASE NASAL GEL FOR DRYNESSNESS AND ALLERGIES

IMPAVIDO FOR ACANTHAMEOEBA KERATITIS

Check some of our Products!

CONTRACT MANUFACTURING

Click here to get in touch with the Profounda Team.

Toll Free: (407) 270-7790

Profounda files new IP

Profounda files new IP

Profounda files its first patent application as it looks to develop its portfolio of pharmaceutical products. Profounda looks for new insights in pharmaceutical product development in order to deliver on its promise of better products. The addition of new IP filings is in line with creating value for our shareholders. #Sightseeing

Featured Posts

Patient survives Brain Eating Amoeba

Profounda OutLicenses right to development product

Profounda OutLicenses right to development product

Company formation complete

Company formation complete

Recent Posts

Generic to Arestin Microspheres by Bausch Health (Orapharma) receives Competitive Generic Therapy De

DOG AND HUMANS GET GREAT RESULTS

Sales exceed $2 Million for first year of Profounda's Commercial Presence in the USA

Orphan drug status approval for Acanthamoeba Keratitis received by Profounda for Miltefosine

Profounda Inc. receives FDA orphan-drug designation for the Treatment of Primary Amebic Meningoencep

CNN report on Survivor of Brain Eating Amoeba

Patient survives Brain Eating Amoeba

Profounda working with local Health Officials in fight to save patients life.

Profounda Licensed in Florida

IMPAVIDO NOW AVAILABLE IN THE USA

Archive

Search By Tags

No tags yet.